Rasimcan Meral
Overview
Explore the profile of Rasimcan Meral including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
304
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meral R, Celik Guler M, Kaba D, Prativadi J, Frontera E, Foss-Freitas M, et al.
Diabetes Care
. 2025 Mar;
PMID: 40063619
Objective: Lipodystrophy encompasses a group of rare disorders associated with severe metabolic disease. These disorders are defined by abnormal fat distribution, with near-total (generalized lipodystrophy [GL]) or partial (partial lipodystrophy...
2.
Brown R, Akinci B, Yosef M, Phillips H, Khalatbari S, Sorkina E, et al.
J Clin Endocrinol Metab
. 2025 Feb;
PMID: 39970125
Context: Lipodystrophy syndromes are rare disorders characterized by deficient adipose tissue, leading to insulin resistance, dyslipidemia, and organ system abnormalities. Objective: Our goal was to develop a lipodystrophy severity score...
3.
Meral R, Celik Guler M, Kaba D, Prativadi J, Frontera E, Foss-Freitas M, et al.
medRxiv
. 2025 Jan;
PMID: 39802778
Background: Lipodystrophy encompasses a group of rare disorders associated with severe metabolic disease. These disorders are defined by abnormal fat distribution, with near-total (generalized lipodystrophy, GL) or partial (partial lipodystrophy,...
4.
Bilgic S, Meral R, Sager M, Sonmezoglu K
BMC Cancer
. 2024 Oct;
24(1):1273.
PMID: 39402494
Purpose: Papillary thyroid cancer (PTC) is the most common thyroid malignancy, characterized by its slow progression and favorable prognosis. This study re-evaluates the efficacy of radioactive iodine (RAI) therapy versus...
5.
Foss-Freitas M, Besci O, Meral R, Neidert A, Chenevert T, Oral E, et al.
Obes Facts
. 2023 Nov;
17(1):103-108.
PMID: 37952526
There is no strong evidence that any specific diet is the preferred treatment for lipodystrophy syndromes. Here we remark on the benefits of a very-low-calorie diet (VLCD) in a patient...
6.
Usta Akgul S, Cinar C, Caliskan Y, Demir E, Cebeci E, Meral R, et al.
Int Urol Nephrol
. 2022 Oct;
55(4):1033-1044.
PMID: 36306048
Purpose: The impact of core 1,3-galactosyltransferase-specific molecular chaperon (COSMC) gene expression and methylation profile on clinical progression of IgA nephropathy (IgAN) is unclear. The aim of this study was to...
7.
Akinci B, Subauste A, Ajluni N, Esfandiari N, Meral R, Neidert A, et al.
Med
. 2022 Mar;
2(7):814-835.
PMID: 35291351
Background: Recombinant leptin therapy reverses nonalcoholic steatohepatitis (NASH) in leptin-deficient lipodystrophy. We inquired if leptin therapy would improve nonalcoholic steatohepatitis in more common forms of this heterogeneous condition. Methods: Nine...
8.
Meral R, Malandrino N, Walter M, Neidert A, Muniyappa R, Arioglu Oral E, et al.
J Clin Endocrinol Metab
. 2021 Oct;
107(4):e1739-e1751.
PMID: 34677608
Context: Leptin replacement with metreleptin improves glycemia and hypertriglyceridemia in severely hypoleptinemic patients with generalized lipodystrophy (GLD), but its effects are variable in partially leptin-deficient patients with partial lipodystrophy (PLD)....
9.
Jalal Eldin A, Akinci B, Monteiro da Rocha A, Meral R, Yildirim Simsir I, Adiyaman S, et al.
Clin Endocrinol (Oxf)
. 2021 Jan;
94(6):1043-1053.
PMID: 33502018
Objectives: LMNA variants have been previously associated with cardiac abnormalities independent of lipodystrophy. We aimed to assess cardiac impact of familial partial lipodystrophy (FPLD) to understand the role of laminopathy...
10.
Koo E, Foss-Freitas M, Meral R, Ozer M, Eldin A, Akinci B, et al.
Obesity (Silver Spring)
. 2021 Jan;
29(2):274-278.
PMID: 33491315
Objective: This study aimed to investigate the shortcoming of BMI as a measurement of adiposity in patients with familial partial lipodystrophy (FPLD). Methods: Two different matching procedures were used to...